Lopinavir/ritonavir regulatory update

FDA granted tentative marketing approval to ANDAs from Cipla for lopinavir/ritonavir, from Hetero for abacavir and from Par's Par Formulations Private Ltd. subsidiary and from Micro Labs for efavirenz...